These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 12122189

  • 1. Acute dopaminergic challenge tests to assess postural/kinetic tremor of different origin: a case report.
    Solida A, Ghika J, Vingerhoets F.
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):206-7. PubMed ID: 12122189
    [No Abstract] [Full Text] [Related]

  • 2. [Prevention and treatment of fluctuations in patients with Parkinson's disease].
    Ludin HP, Surber Ch.
    Praxis (Bern 1994); 2006 Dec 20; 95(51-52):2013-8. PubMed ID: 17294589
    [Abstract] [Full Text] [Related]

  • 3. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P, Lenz FA, Chase TN.
    Mov Disord; 1998 Mar 20; 13(2):354-6. PubMed ID: 9539355
    [No Abstract] [Full Text] [Related]

  • 4. Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR).
    Makela EH, Cutlip WD.
    J Neuropsychiatry Clin Neurosci; 1992 Mar 20; 4(2):234-5. PubMed ID: 1627988
    [No Abstract] [Full Text] [Related]

  • 5. Marijuana for parkinsonian tremor.
    Frankel JP, Hughes A, Lees AJ, Stern GM.
    J Neurol Neurosurg Psychiatry; 1990 May 20; 53(5):436. PubMed ID: 2351975
    [No Abstract] [Full Text] [Related]

  • 6. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.
    Prasher D, Findley L.
    J Neurol Neurosurg Psychiatry; 1991 Jul 20; 54(7):603-9. PubMed ID: 1895125
    [Abstract] [Full Text] [Related]

  • 7. Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers.
    Burleigh-Jacobs A, Horak FB, Nutt JG, Obeso JA.
    Mov Disord; 1997 Mar 20; 12(2):206-15. PubMed ID: 9087979
    [Abstract] [Full Text] [Related]

  • 8. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC, Horstink MW, Roos RA, Jansen EN.
    Adv Neurol; 1993 Mar 20; 60():648-52. PubMed ID: 8420204
    [No Abstract] [Full Text] [Related]

  • 9. Amantadine-induced "vocal" myoclonus.
    Pfeiffer RF.
    Mov Disord; 1996 Jan 20; 11(1):104-6. PubMed ID: 8771080
    [No Abstract] [Full Text] [Related]

  • 10. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.
    Med Lett Drugs Ther; 2015 Aug 03; 57(1474):112. PubMed ID: 26218794
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
    Colosimo C, Merello M, Hughes AJ, Sieradzan K, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1996 Jun 03; 60(6):634-7. PubMed ID: 8648329
    [Abstract] [Full Text] [Related]

  • 14. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
    Facca A, Sanchez-Ramos J.
    Mov Disord; 1996 May 03; 11(3):327-9. PubMed ID: 8723153
    [No Abstract] [Full Text] [Related]

  • 15. Tremor.
    Sethi KD.
    Curr Opin Neurol; 2003 Aug 03; 16(4):481-5. PubMed ID: 12869807
    [Abstract] [Full Text] [Related]

  • 16. Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
    Deutschländer A, Asmus F, Marelli E, Klopstock T, Gasser T, Bötzel K.
    Mov Disord; 2006 Sep 03; 21(9):1523-5. PubMed ID: 16755578
    [Abstract] [Full Text] [Related]

  • 17. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease.
    Zappia M, Montesanti R, Colao R, Branca D, Nicoletti G, Aguglia U, Quattrone A.
    Mov Disord; 1997 Jan 03; 12(1):103-6. PubMed ID: 8990062
    [Abstract] [Full Text] [Related]

  • 18. Effect of Levodopa + Carbidopa on the Laryngeal Electromyographic Pattern in Parkinson Disease.
    Noffs G, de Campos Duprat A, Zarzur AP, Cury RG, Cataldo BO, Fonoff E.
    J Voice; 2017 May 03; 31(3):383.e19-383.e23. PubMed ID: 27839704
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations.
    Benetello P, Furlanut M, Zara G, Baraldo M, Hassan E.
    Eur Neurol; 1993 May 03; 33(1):69-73. PubMed ID: 8440292
    [Abstract] [Full Text] [Related]

  • 20. Off-period screaming accompanying motor fluctuations in Parkinson's disease.
    Steiger MJ, Quinn NP, Toone B, Marsden CD.
    Mov Disord; 1991 May 03; 6(1):89-90. PubMed ID: 2005932
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.